Related Experiment Video
Updated: Jul 12, 2026

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
Published on: June 23, 2026
CLiBE: a database of computed ligand binding energy for ligand-receptor complexes
A new database of ligand-receptor interaction energy aids drug design by predicting binding competitiveness. Computed energies show correlation with experimental binding affinity, useful for qualitative analysis.
Area of Science:
- Computational chemistry
- Pharmacology
- Structural biology
Background:
- Drug development requires understanding binding competitiveness against natural ligands and other drugs.
- Computer-aided drug design (CADD) can evaluate ligand-receptor interactions for rational drug development.
Purpose of the Study:
- To develop a database of ligand-receptor interaction energy to aid in assessing drug binding competitiveness.
- To validate the utility of computed interaction energies in predicting binding affinity.
Main Methods:
- A database of ligand-receptor interaction energies was created using 3D structures from the Protein Data Bank (PDB).
- Molecular mechanics force fields were employed for energy computation, consistent with methods used for predicting drug targets.
- Computed energies were compared against experimental binding affinity data for known ligand-receptor complexes.
Main Results:
- A database containing computed ligand-receptor interaction energies and associated ligand information was established.
- A correlation was observed between the computed interaction energy and experimental binding affinity.
- The computed energies provide insights into binding modes and other interaction profiles.
Conclusions:
- The developed database and computed energies can facilitate the rational development of potent drug candidates.
- Computed ligand-receptor interaction energy shows potential for qualitative analysis of drug binding competitiveness.
- This approach supports CADD strategies by providing a tool to evaluate drug-target interactions.
More Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
14:34A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
Published on: April 3, 2026
Related Concept Videos
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
The Equilibrium Binding Constant and Binding Strength
The Equilibrium Binding Constant and Binding Strength
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...